Webinar - New Emphasis of Lipoprotein Particles for Cardiovascular Risk Assessment

Now Offering COVID-19 PCR and Antibody Testing. Learn More

 

 

The New Emphasis of Lipoprotein Particles for Cardiovascular Risk Assessment

Presented by Jan Troup, Ph.D.

 

Learning Objectives:

  • Addressing the new emphasis of lipoprotein particles over cholesterol for lipid management
  • ATP IV has been canceled: Particles are in  and cholesterol is out
  • Review the enhancements of the LPP technology
  • Learn how lipoprotein subgroup measurement provides a better risk assessment and therapeutic approach
     
Watch Now